User profiles for Anthony Rodgers

Anthony Rodgers

Professor of Global Health
Verified email at georgeinstitute.org
Cited by 128962

Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial

…, S Bompoint, S Stepien, R Whittaker, A Rodgers… - Jama, 2015 - jamanetwork.com
Importance Cardiovascular disease prevention, including lifestyle modification, is important
but underutilized. Mobile health strategies could address this gap but lack evidence of …

Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study

…, M Reitsma, ALP Ribeiro, N Rigotti, A Rodgers… - Journal of the American …, 2020 - jacc.org
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are
the leading cause of global mortality and a major contributor to disability. This paper reviews …

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

…, T Callender, J Emberson, J Chalmers, A Rodgers… - The Lancet, 2016 - thelancet.com
Background The benefits of blood pressure lowering treatment for prevention of cardiovascular
disease are well established. However, the extent to which these effects differ by …

[HTML][HTML] Interpretation of the evidence for the efficacy and safety of statin therapy

…, N Poulter, D Preiss, P Ridker, I Roberts, A Rodgers… - The Lancet, 2016 - thelancet.com
This Review is intended to help clinicians, patients, and the public make informed decisions
about statin therapy for the prevention of heart attacks and strokes. It explains how the …

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

…, J Mant, A Salam, K Rahimi, V Perkovic, A Rodgers - The Lancet, 2016 - thelancet.com
Background Recent hypertension guidelines have reversed previous recommendations for
lower blood pressure targets in high-risk patients, such as those with cardiovascular disease, …

[HTML][HTML] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an …

…, J Lubsen, E Malacco, B Neal, V Perkovic, A Rodgers… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …

Worldwide access to treatment for end-stage kidney disease: a systematic review

…, I Okpechi, M Zhao, J Lv, AX Garg, J Knight, A Rodgers… - The Lancet, 2015 - thelancet.com
Background End-stage kidney disease is a leading cause of morbidity and mortality worldwide.
Prevalence of the disease and worldwide use of renal replacement therapy (RRT) are …

Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis

…, K Santo, A Thiagalingam, A Rodgers… - JAMA internal …, 2016 - jamanetwork.com
Importance Adherence to long-term therapies in chronic disease is poor. Traditional
interventions to improve adherence are complex and not widely effective. Mobile telephone text …

Mobile phone‐based interventions for smoking cessation

…, H McRobbie, C Bullen, A Rodgers… - … of systematic reviews, 2016 - cochranelibrary.com
Background Access to mobile phones continues to increase exponentially globally, outstripping
access to fixed telephone lines, fixed computers and the Internet. Mobile phones are an …

[HTML][HTML] Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

…, V Perkovic, N Poulter, A Rodgers… - … England Journal of …, 2014 - Mass Medical Soc
Background In the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified
Release Controlled Evaluation (ADVANCE) factorial trial, the combination of perindopril …